List of works - Ricardo Russo

13.4 High frequency of CNS involvement in linear scleroderma of the face.

scientific article published on 15 September 2008

14.2 Causes of early death in juvenile onset systemic lupus erythematosus (JSLE).

scientific article published on 15 September 2008

2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Juvenile Dermatomyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology

scientific article published on May 2017

2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Juvenile Dermatomyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology

scientific article published on 6 April 2017

2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Coll

scientific article published on 28 August 2015

2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Coll

scientific article published on March 2016

A preliminary disease severity score for juvenile systemic sclerosis

scientific article published in December 2012

An international delphi survey for the definition of the variables for the development of new classification criteria for periodic fever aphtous stomatitis pharingitis cervical adenitis (PFAPA).

scientific article published on 18 April 2018

Autoinflammatory diseases

scientific article

Biologic agents in juvenile spondyloarthropathies

scientific article

Blau Syndrome-Associated Uveitis: Preliminary Results From an International Prospective Interventional Case Series.

scientific article published on 5 September 2017

Blau syndrome: cross-sectional data from a multicentre study of clinical, radiological and functional outcomes.

scientific article

Chronic infantile neurological cutaneous and articular/neonatal onset multisystem inflammatory disease syndrome: ocular manifestations in a recently recognized chronic inflammatory disease of childhood

scientific article published on 01 October 2000

Classification of juvenile spondyloarthropaties according to asas criteria.

scientific article published on 17 September 2014

Clinical characteristics of children with Juvenile Systemic Sclerosis: follow-up of 23 patients in a single tertiary center.

scientific article published on May 2007

Clinical features, treatment, and outcome of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a multinational, multicenter study of 362 patients.

scientific article published on November 2014

Clinical remission in patients with systemic juvenile idiopathic arthritis treated with anti-tumor necrosis factor agents.

scientific article published in May 2009

Consensus-based recommendations for the management of juvenile dermatomyositis.

scientific article published on 11 August 2016

De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases

scientific article

Development of a consensus core dataset in juvenile dermatomyositis for clinical use to inform research

scientific article

Development of new classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis.

scientific article

Development of the autoinflammatory disease damage index (ADDI).

scientific article published on 3 November 2016

EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part I: Overall methodology and clinical characterisation

scientific article

Efficacy and safety of canakinumab therapy in paediatric patients with cryopyrin-associated periodic syndrome: a single-centre, real-world experience.

scientific article published on 17 December 2013

Expert consensus on dynamics of laboratory tests for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis.

scientific article published on 19 January 2016

Genetic architecture distinguishes systemic juvenile idiopathic arthritis from other forms of juvenile idiopathic arthritis: clinical and therapeutic implications

article

Global damage in systemic juvenile idiopathic arthritis: preliminary early predictors

scientific article published on 01 April 2008

HLA-DRB1*11 and variants of the MHC class II locus are strong risk factors for systemic juvenile idiopathic arthritis

scientific article

IL1RN Variation Influences both Disease Susceptibility and Response to Human Recombinant IL-1RA Therapy in Systemic Juvenile Idiopathic Arthritis.

scientific article published on 2 April 2018

Interferon-beta1a-induced juvenile chronic arthritis in a genetically predisposed young patient with multiple sclerosis: comment on the case report by Levesque et al

scientific article published on 01 May 2000

Localized scleroderma in childhood is not just a skin disease.

scientific article published in September 2005

Long-term outcome and prognostic factors of juvenile dermatomyositis: a multinational, multicenter study of 490 patients

scientific article published on 01 January 2010

Monogenic autoinflammatory diseases

scientific article published on 15 May 2014

Multicentric prevalence study of anti P ribosomal autoantibodies in juvenile onset systemic lupus erythematosus compared with adult onset systemic lupus erythematosus.

scientific article published on 9 May 2014

Neuromyelitis optica associated with systemic autoimmune diseases in children

scientific article published on 15 September 2008

PReS-FINAL-2120: Juvenile scleroderma international network (JUSINET) database: a reliable instrument for clinical research in juvenile scleroderma syndromes.

scientific article published on 5 December 2013

PReS-FINAL-2236: Continuous autoinflammatory syndromes: a single-center experience in Argentina.

scientific article published on 5 December 2013

Patients with early-onset systemic juvenile idiopathic arthritis show more inflammation and worse outcome

Patients with very early-onset systemic juvenile idiopathic arthritis exhibit more inflammatory features and a worse outcome

scientific article published on 15 January 2013

Recommendations for the management of autoinflammatory diseases.

scientific article published on 24 June 2015

SHARE – workpackage 5: evidence based recommendations for diagnosis and treatment of juvenile dermatomyositis.

scientific article published on 17 September 2014

SHARE – workpackage 5: evidence based recommendations for diagnosis and treatment of juvenile localized scleroderma and juvenile systemic sclerosis

scientific article published on 17 September 2014

Share – Workpackage 5: evidence based recommendations for diagnosis and treatment of juvenile idiopathic arthritis.

scientific article published on 17 September 2014

Systemic juvenile idiopathic arthritis is associated with HLA-DRB1 in Europeans and Americans of European descent

scientific article

Systemic sclerosis in childhood: clinical and immunologic features of 153 patients in an international database

scientific article published on 01 December 2006

The Phenotype and Genotype of Mevalonate Kinase Deficiency: A Series of 114 Cases From the Eurofever Registry

scientific article

The juvenile systemic sclerosis clinic: an interdisciplinary approach.

scientific article published on 13 July 2012

Tocilizumab in JIA patients who have inadequate response to anti-tumour necrosis factor therapy.

scientific article published on 14 September 2011

Tolerance of parenteral, higher dose methotrexate in children with juvenile chronic arthritis

scientific article published on 01 May 2000

Use of infliximab in patients with systemic juvenile idiopathic arthritis refractory to etanercept.

scientific article

Validation of Relapse Risk Biomarkers for Routine Use in Patients With Juvenile Idiopathic Arthritis

scientific article published on 01 June 2014

[Takayasu arteritis in pediatric patients]

scientific article published on 01 May 2012

List of works by Ricardo Russo

13.4 High frequency of CNS involvement in linear scleroderma of the face.

14.2 Causes of early death in juvenile onset systemic lupus erythematosus (JSLE).

2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Juvenile Dermatomyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology

2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Juvenile Dermatomyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology

2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Coll

2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Coll

A preliminary disease severity score for juvenile systemic sclerosis

An international delphi survey for the definition of the variables for the development of new classification criteria for periodic fever aphtous stomatitis pharingitis cervical adenitis (PFAPA).

Autoinflammatory diseases

Biologic agents in juvenile spondyloarthropathies

Blau Syndrome-Associated Uveitis: Preliminary Results From an International Prospective Interventional Case Series.

Blau syndrome: cross-sectional data from a multicentre study of clinical, radiological and functional outcomes.

Chronic infantile neurological cutaneous and articular/neonatal onset multisystem inflammatory disease syndrome: ocular manifestations in a recently recognized chronic inflammatory disease of childhood

Classification of juvenile spondyloarthropaties according to asas criteria.

Clinical characteristics of children with Juvenile Systemic Sclerosis: follow-up of 23 patients in a single tertiary center.

Clinical features, treatment, and outcome of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a multinational, multicenter study of 362 patients.

Clinical remission in patients with systemic juvenile idiopathic arthritis treated with anti-tumor necrosis factor agents.

Consensus-based recommendations for the management of juvenile dermatomyositis.

De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases

Development of a consensus core dataset in juvenile dermatomyositis for clinical use to inform research

Development of new classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis.

Development of the autoinflammatory disease damage index (ADDI).

EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part I: Overall methodology and clinical characterisation

Efficacy and safety of canakinumab therapy in paediatric patients with cryopyrin-associated periodic syndrome: a single-centre, real-world experience.

Expert consensus on dynamics of laboratory tests for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis.

Genetic architecture distinguishes systemic juvenile idiopathic arthritis from other forms of juvenile idiopathic arthritis: clinical and therapeutic implications

Global damage in systemic juvenile idiopathic arthritis: preliminary early predictors

HLA-DRB1*11 and variants of the MHC class II locus are strong risk factors for systemic juvenile idiopathic arthritis

IL1RN Variation Influences both Disease Susceptibility and Response to Human Recombinant IL-1RA Therapy in Systemic Juvenile Idiopathic Arthritis.

Interferon-beta1a-induced juvenile chronic arthritis in a genetically predisposed young patient with multiple sclerosis: comment on the case report by Levesque et al

Localized scleroderma in childhood is not just a skin disease.

Long-term outcome and prognostic factors of juvenile dermatomyositis: a multinational, multicenter study of 490 patients

Monogenic autoinflammatory diseases

Multicentric prevalence study of anti P ribosomal autoantibodies in juvenile onset systemic lupus erythematosus compared with adult onset systemic lupus erythematosus.

Neuromyelitis optica associated with systemic autoimmune diseases in children

PReS-FINAL-2120: Juvenile scleroderma international network (JUSINET) database: a reliable instrument for clinical research in juvenile scleroderma syndromes.

PReS-FINAL-2236: Continuous autoinflammatory syndromes: a single-center experience in Argentina.

Patients with early-onset systemic juvenile idiopathic arthritis show more inflammation and worse outcome

Patients with very early-onset systemic juvenile idiopathic arthritis exhibit more inflammatory features and a worse outcome

Recommendations for the management of autoinflammatory diseases.

SHARE – workpackage 5: evidence based recommendations for diagnosis and treatment of juvenile dermatomyositis.

SHARE – workpackage 5: evidence based recommendations for diagnosis and treatment of juvenile localized scleroderma and juvenile systemic sclerosis

Share – Workpackage 5: evidence based recommendations for diagnosis and treatment of juvenile idiopathic arthritis.

Systemic juvenile idiopathic arthritis is associated with HLA-DRB1 in Europeans and Americans of European descent

Systemic sclerosis in childhood: clinical and immunologic features of 153 patients in an international database

The Phenotype and Genotype of Mevalonate Kinase Deficiency: A Series of 114 Cases From the Eurofever Registry

The juvenile systemic sclerosis clinic: an interdisciplinary approach.

Tocilizumab in JIA patients who have inadequate response to anti-tumour necrosis factor therapy.

Tolerance of parenteral, higher dose methotrexate in children with juvenile chronic arthritis

Use of infliximab in patients with systemic juvenile idiopathic arthritis refractory to etanercept.

Validation of Relapse Risk Biomarkers for Routine Use in Patients With Juvenile Idiopathic Arthritis

[Takayasu arteritis in pediatric patients]